D
89bio, Inc.
ETNB
$9.08
$0.202.25%
D
Sell
4/13/2023Upgraded
89bio, Inc. (ETNB) was upgraded to D- from E+ on 4/13/2023 due to an increase in the total return index and volatility index.
89bio, Inc. (ETNB) was upgraded to D- from E+ on 4/13/2023 due to an increase in the total return index and volatility index.
E
Sell
3/29/2023Downgrade
89bio, Inc. (ETNB) was downgraded to E+ from D- on 3/29/2023 due to a decline in the valuation index and solvency index.
89bio, Inc. (ETNB) was downgraded to E+ from D- on 3/29/2023 due to a decline in the valuation index and solvency index.
D
Sell
3/14/2023Downgrade
89bio, Inc. (ETNB) was downgraded to D- from D on 03/14/2023.
89bio, Inc. (ETNB) was downgraded to D- from D on 03/14/2023.
D
Sell
2/23/2023Upgraded
89bio, Inc. (ETNB) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
89bio, Inc. (ETNB) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
D
Sell
2/8/2023Downgrade
89bio, Inc. (ETNB) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
89bio, Inc. (ETNB) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
D
Sell
10/17/2022Upgraded
89bio, Inc. (ETNB) was upgraded to D from D- on 10/17/2022 due to a noticeable increase in the total return index, volatility index and growth index. Operating cash flow increased 39.06% from -$24.34M to -$14.84M, earnings per share increased from -$1.2569 to -$1.2311, and EBIT increased 1.47% from -$25.11M to -$24.74M.
89bio, Inc. (ETNB) was upgraded to D from D- on 10/17/2022 due to a noticeable increase in the total return index, volatility index and growth index. Operating cash flow increased 39.06% from -$24.34M to -$14.84M, earnings per share increased from -$1.2569 to -$1.2311, and EBIT increased 1.47% from -$25.11M to -$24.74M.
D
Sell
8/9/2022Upgraded
89bio, Inc. (ETNB) was upgraded to D- from E+ on 8/9/2022 due to an increase in the volatility index and total return index.
89bio, Inc. (ETNB) was upgraded to D- from E+ on 8/9/2022 due to an increase in the volatility index and total return index.
E
Sell
5/13/2022Downgrade
89bio, Inc. (ETNB) was downgraded to E+ from D- on 5/13/2022 due to a decline in the growth index and solvency index. Debt to equity increased from 0.15 to 0.19, and the quick ratio declined from 7.71 to 6.85.
89bio, Inc. (ETNB) was downgraded to E+ from D- on 5/13/2022 due to a decline in the growth index and solvency index. Debt to equity increased from 0.15 to 0.19, and the quick ratio declined from 7.71 to 6.85.
D
Sell
5/5/2022Upgraded
89bio, Inc. (ETNB) was upgraded to D- from E+ on 5/5/2022 due to an increase in the valuation index.
89bio, Inc. (ETNB) was upgraded to D- from E+ on 5/5/2022 due to an increase in the valuation index.
E
Sell
4/20/2022Downgrade
89bio, Inc. (ETNB) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index, growth index and solvency index. Debt to equity increased from 0.01 to 0.15, operating cash flow declined 109.96% from -$13.45M to -$28.24M, and the quick ratio declined from 7.93 to 7.71.
89bio, Inc. (ETNB) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index, growth index and solvency index. Debt to equity increased from 0.01 to 0.15, operating cash flow declined 109.96% from -$13.45M to -$28.24M, and the quick ratio declined from 7.93 to 7.71.
D
Sell
12/10/2021Downgrade
89bio, Inc. (ETNB) was downgraded to D- from D on 12/10/2021 due to a decline in the solvency index, volatility index and total return index. The quick ratio declined from 22.55 to 7.93.
89bio, Inc. (ETNB) was downgraded to D- from D on 12/10/2021 due to a decline in the solvency index, volatility index and total return index. The quick ratio declined from 22.55 to 7.93.
D
Sell
11/5/2021Upgraded
89bio, Inc. (ETNB) was upgraded to D from D- on 11/5/2021 due to an increase in the total return index and volatility index.
89bio, Inc. (ETNB) was upgraded to D from D- on 11/5/2021 due to an increase in the total return index and volatility index.
D
Sell
8/13/2021Downgrade
89bio, Inc. (ETNB) was downgraded to D- from D on 8/13/2021 due to a noticeable decline in the volatility index, total return index and growth index. Earnings per share declined from -$0.7387 to -$1.033, EBIT declined 39.43% from -$14.74M to -$20.55M, and operating cash flow declined 34.22% from -$14.98M to -$20.11M.
89bio, Inc. (ETNB) was downgraded to D- from D on 8/13/2021 due to a noticeable decline in the volatility index, total return index and growth index. Earnings per share declined from -$0.7387 to -$1.033, EBIT declined 39.43% from -$14.74M to -$20.55M, and operating cash flow declined 34.22% from -$14.98M to -$20.11M.
D
Sell
12/1/2020Upgraded
89bio, Inc. (ETNB) was upgraded to D from D- on 12/1/2020 due to an increase in the valuation index and solvency index. The quick ratio increased from 10.88 to 23.25.
89bio, Inc. (ETNB) was upgraded to D from D- on 12/1/2020 due to an increase in the valuation index and solvency index. The quick ratio increased from 10.88 to 23.25.
D
Sell
8/3/2020Upgraded
89bio, Inc. (ETNB) was upgraded to D- from E on 8/3/2020 due to a large increase in the growth index, efficiency index and total return index.
89bio, Inc. (ETNB) was upgraded to D- from E on 8/3/2020 due to a large increase in the growth index, efficiency index and total return index.
E
Sell
5/15/2020Downgrade
89bio, Inc. (ETNB) was downgraded to E from E+ on 5/15/2020 due to a decline in the solvency index, valuation index and volatility index. The quick ratio declined from 16.64 to 10.98.
89bio, Inc. (ETNB) was downgraded to E from E+ on 5/15/2020 due to a decline in the solvency index, valuation index and volatility index. The quick ratio declined from 16.64 to 10.98.
E
Sell
5/1/2020Upgraded
89bio, Inc. (ETNB) was upgraded to E+ from E on 5/1/2020 due to an increase in the total return index.
89bio, Inc. (ETNB) was upgraded to E+ from E on 5/1/2020 due to an increase in the total return index.
E
Sell
4/23/2020Upgraded
89bio, Inc. (ETNB) was upgraded to E from E- on 4/23/2020 due to an increase in the volatility index and valuation index.
89bio, Inc. (ETNB) was upgraded to E from E- on 4/23/2020 due to an increase in the volatility index and valuation index.
E
Sell
4/8/2020Downgrade
89bio, Inc. (ETNB) was downgraded to E- from E on 4/8/2020 due to a decline in the volatility index and valuation index.
89bio, Inc. (ETNB) was downgraded to E- from E on 4/8/2020 due to a decline in the volatility index and valuation index.
E
Sell
3/24/2020Upgraded
89bio, Inc. (ETNB) was upgraded to E from E- on 3/24/2020 due to a noticeable increase in the solvency index, volatility index and growth index. The quick ratio increased from 2.47 to 16.64, and earnings per share increased from -$30.6351 to -$2.5757.
89bio, Inc. (ETNB) was upgraded to E from E- on 3/24/2020 due to a noticeable increase in the solvency index, volatility index and growth index. The quick ratio increased from 2.47 to 16.64, and earnings per share increased from -$30.6351 to -$2.5757.
E
Sell
3/16/2020Downgrade
89bio, Inc. (ETNB) was downgraded to E- from E on 3/16/2020 due to a significant decline in the volatility index.
89bio, Inc. (ETNB) was downgraded to E- from E on 3/16/2020 due to a significant decline in the volatility index.
E
Sell
2/6/2020None
89bio, Inc. (ETNB) was downgraded to E from U on 02/06/2020.
89bio, Inc. (ETNB) was downgraded to E from U on 02/06/2020.
NASDAQ
04/19/2024 4:00PM Eastern
Quotes delayed
